Amylase, Body Fluid




Test Mnemonic

FAMYL

CPT Codes

  • 82150 - QTY (1)

LOINC ®

1795-4

Performing Laboratory

Cleveland Clinic Laboratories


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLFluid, bodySterile container RefrigeratedViscous specimens will be rejected. Indicate source of fluid.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
0.5 mL     

Stability

Environmental Condition Description
Ambient7 days
Refrigerated7 days
FrozenUnacceptable

Days Performed

Sun - Sat

Turnaround Time

8 hours

Methodology

Name Description
Enzymatic 

Reference Range

Amylase, Body Fluid
Sex Age From Age To Type Range Range Unit
       Refer to Clinical Information 

Special Info

Indicate body fluid type/source.

Clinical Info

Pleural fluids: Amylase measurement in pleural fluid is considered a useful test for detecting amylase-rich pleural effusions, which may be caused by exudative conditions associated with pancreatitis, esophageal rupture, malignancy, pneumonia, and liver cirrhosis. A ratio of pleural fluid amylase to a concurrent serum amylase >1 is defined as an amylase-rich pleural effusion. Peritoneal fluids and drainage fluids: Pancreatic damage causes extravasation of amylase from the exocrine cells into the peritoneal space. In cases of pancreatitis, fluid amylase should be at least several-fold times higher in fluid of pancreatic origin compared to concurrent serum amylase values. Pancreatic cyst fluid: Pancreatic cyst fluid amylase may aid in characterizing tumors and should be interpreted along with other clinical and laboratory information. References: 1. Block DR, Algeciras-Schimnich A. Body fluid analysis: clinical utility and applicability of published studies to guide interpretation of today’s laboratory testing in serous fluids. Crit Rev Clin Lab Sci, 2013;50(4-5):107-124. 2. CLSI. Analysis of Body Fluids in Clinical Chemistry; Approved Guideline. CLSI document C49-A. Wayne, PA: Clinical Laboratory Standards Institute; 2007. 3. Snozek CLH, Mascarenhas RC, O’Kane DJ. Use of cyst fluid CEA, CA19-9, and amylase for evaluation of pancreatic lesions. Clinical Biochemistry. 2009;42:1585-1588.